Form 4 Filing for Alignment Healthcare, Inc.

2026-06-12SEC Filing 4 (0001628280-26-042824)

This filing details transactions by John E. Kao, Chief Executive Officer and Director of Alignment Healthcare, Inc. On June 10, 2026, Mr. Kao disposed of 74,936 shares of Common Stock with a weighted-average price of $19.6481 and 223,064 shares of Common Stock with a weighted-average price of $20.5962. These transactions were made under a Rule 10b5-1 plan adopted on November 21, 2025. The reported prices are weighted-averages, with actual sale prices ranging from $19.12 to $20.11 for the first transaction and $20.12 to $20.89 for the second. Some shares were transferred to the JEK Trust, of which Mr. Kao is the trustee. Following these transactions, Mr. Kao directly owns 1,608,743 shares.